Skip to Content

93/11 (Pantoprazole sodium delayed-release 20 mg)

Pill with imprint 93/11 is Yellow, Elliptical / Oval and has been identified as Pantoprazole sodium delayed-release 20 mg. It is supplied by Teva Pharmaceuticals USA.

Pantoprazole is used in the treatment of barrett's esophagus; erosive esophagitis; duodenal ulcer; gerd; gastritis/duodenitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93/11

Pantoprazole sodium delayed-release 20 mg 93/11
Pantoprazole sodium delayed-release 20 mg 93/11
Pantoprazole sodium delayed-release 20 mg 93/11  Front
Pantoprazole sodium delayed-release 20 mg 93/11  Back
Pantoprazole sodium delayed-release 20 mg 93/11

Pantoprazole sodium delayed-release

Imprint
93/11
Strength
20 mg
Color
Yellow
Size
8.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Proton pump inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
Inactive Ingredients
calcium carbonate, calcium stearate, D&C Yellow No. 10, FD&C Yellow No. 6, hypromellose 2910 (15 mPa.s), ferrosoferric oxide, ferric oxide yellow, lactose monohydrate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, microcrystalline cellulose, polyethylene glycol 4000, propylene glycol, shellac, sodium carbonate, stearic acid, magnesium silicate, titanium dioxide, triethyl citrate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00093-0011 Teva Pharmaceuticals USA, Inc.
42291-0658 AvKare, Inc.

Get help with Imprint Code FAQs.

Related Images for "93/11"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.